The role of infliximab in treating refractory cardiac sarcoidosis

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Raheel Ahmed

Freeman Hospital, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail

Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B study

Professor T. Damy (Creteil, FR)

Abstract Slides Video

Presentation thumbnail

Acoramidis produces near-complete TTR stabilization in blood samples from patients with variant transthyretin amyloidosis that is greater than that achieved with tafamidis

Mr A. Ji (San Francisco, US)

Abstract Slides Video

Presentation thumbnail

The use of 99mTc-PYP SPECT/CT in monitoring therapeutic changes of eplontersen in patients with hereditary transthyretin cardiomyopathy

Doctor A. Yu (Hsinchu, TW)

Abstract Slides Video

Presentation thumbnail

Survival analysis of tafamidis use in patients with ATTR cardiac amyloidosis

Doctor N. Starr (Co. Limerick, IE)

Abstract Slides Video

Presentation thumbnail

Non-adherence to prescribed medications in ambulatory patients with heart failure assessed using liquid chromatography tandem mass spectrometry

Doctor S. Sze (Leicester, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure red flags and their management

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Presentation

Treating heart failure in adult congenital heart disease: A-Z

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources